Related Experiment Video
Updated: May 15, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Palliative care opportunities for women with advanced ovarian cancer associated with intraperitoneal chemotherapy
Shirley Otis-Green1, Mark T Wakabayashi, Robert Morgan
1City of Hope, Duarte, California 91010-3000, USA. Sotis-green@coh.org
Abstract:
Intraperitoneal chemotherapy poses both potential benefits as a cancer treatment and negative consequences on patient and family quality of life. The profound multi-dimensional quality of life impact of intraperitoneal (IP) chemotherapy upon women with advanced ovarian cancer makes the early integration of palliative care particularly important for this population. Numerous opportunities occur throughout the treatment process to improve the delivery of biopsychosocial-spiritual support to women receiving IP chemotherapy.
Related Concept Videos
Continuing Care
Treatment Resistant Cancers
